Ethris and Thermo Fisher partner on mRNA solutions
The collaboration will expand global access to Ethris' suite of mRNA technologies.
Trilink Thematic mRNA WP
Moderna’s mRNA RSV vaccine wins expanded FDA approval for younger adults
Innorna secures dual FDA designations for Wilson’s disease mRNA therapy
Ethris and Lonza to develop mRNA vaccines for respiratory conditions
FDA fast tracks Sanofi’s mRNA vaccine for chlamydia
FDA approves IND application for Everest’s cancer vaccine
MHRA seeks input on new regulatory guidance for cancer vaccines
HHS awards $590m to Moderna for mRNA ‘flu vax development
